Mydecine Innovations Group Inc (MYCO.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 7 | 58 |
| Cost of Goods | N/A | N/A | 0 | 0 | 37 |
| Gross Profit | N/A | N/A | 0 | 7 | 21 |
| Operating Expenses | 2,531 | 9,548 | 16,389 | 22,692 | 11,654 |
| Operating Income | -2,531 | -9,548 | -16,389 | -22,684 | -11,633 |
| Interest Expense | 1,449 | 1,303 | 912 | 205 | 183 |
| Other Income | 828 | -10,096 | 59 | -694 | -15,133 |
| Pre-tax Income | -3,152 | -20,947 | -17,242 | -23,583 | -26,949 |
| Net Income Continuous | -3,152 | -20,947 | -17,242 | -23,583 | -26,949 |
| Net Income Discontinuous | N/A | 0 | 5,675 | -5,314 | N/A |
| Net Income | $-3,152 | $-20,947 | $-11,567 | $-28,897 | $-26,949 |
| EPS Basic Total Ops | -2.50 | -34.00 | -67.00 | -350.00 | -600.00 |
| EPS Basic Continuous Ops | -2.50 | -34.00 | -67.00 | -300.00 | -600.00 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | 32.81 | -50.00 | N/A |
| EPS Diluted Total Ops | -2.50 | -34.00 | -67.00 | -350.00 | -600.00 |
| EPS Diluted Continuous Ops | -2.50 | -34.00 | -67.00 | -300.00 | -600.00 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | 32.81 | -50.00 | N/A |
| EBITDA(a) | $-1,703 | $-19,634 | $-16,201 | $-23,142 | $-26,676 |